Back
Akero Therapeutics Vs. Eli Lilly and Industry Stock Comparison
Buy
55
AKRO
Akero Therapeutics
Last Price:
16.75
Seasonality Move:
-0.92%
Buy
53
LLY
Eli Lilly and
Last Price:
587.75
Seasonality Move:
3.65%
Buy
55
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $16.66. The Score for AKRO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Eli Lilly and (LLY)
is a Buy
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $591.86. The Score for LLY is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- LLY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $16.66
The current trend is relatively stagnant and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $591.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LLY is experiencing slight buying pressure.
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.3 | Sell |
| Relative Strength Index (14 RSI): | 46.26 | Sell |
| Chaikin Money Flow: | -560846 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.77 - 16.11) | Buy |
| Bollinger Bands (100): | (19.33 - 50.89) | Sell |
LLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.82 | Buy |
| Relative Strength Index (14 RSI): | 51.18 | Buy |
| Chaikin Money Flow: | 895076 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (570.79 - 604.75) | Buy |
| Bollinger Bands (100): | (494.2 - 600.14) | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.24 | Buy |
| 20-day SMA: | 15.13 | Buy |
| 50-day SMA: | 23.61 | Sell |
| 200-day SMA: | 39.89 | Sell |
| 8-day EMA: | 16.09 | Buy |
| 20-day EMA: | 16.19 | Buy |
| 50-day EMA: | 22.53 | Sell |
| 200-day EMA: | 34.98 | Sell |
LLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 594.14 | Sell |
| 20-day SMA: | 592.99 | Sell |
| 50-day SMA: | 579.05 | Buy |
| 200-day SMA: | 468.95 | Buy |
| 8-day EMA: | 593.77 | Sell |
| 20-day EMA: | 591.75 | Buy |
| 50-day EMA: | 578.5 | Buy |
| 200-day EMA: | 492.11 | Buy |
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and a decrease next year of $0.77 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.03 per share, and an increase next year of $5.67 per share.
Akero Therapeutics Technical Analysis
| Nov 15 | Nov 16 | Nov 17 | Nov 20 | Nov 21 | Nov 22 | Nov 24 | Nov 27 | Nov 28 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 16 | 17 | 20 | 21 | 22 | 24 | 27 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Eli Lilly and Technical Analysis
| Nov 15 | Nov 16 | Nov 17 | Nov 20 | Nov 21 | Nov 22 | Nov 24 | Nov 27 | Nov 28 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 16 | 17 | 20 | 21 | 22 | 24 | 27 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||